Nephrocare Health Services Limited (0542669D IN)

Nephrocare Health Services is looking to raise US$232mn in its upcoming India IPO. The deal will be run by Nomura, IIFL Capital, Ambit and ICICI Securities. Nephrocare Health Services Limited (NHS), also known as NephroPlus, is India’s largest dialysis provider, offering end-to-end kidney care through 490 clinics, including 43 across the Philippines, Uzbekistan, and Nepal. These clinics have been established through a combination of greenfield setups, brownfield acquisitions, and public-private partnerships (PPP). NHS’ core services include haemodialysis, home and mobile dialysis, and pharmacy support. It also provides wellness services like nutrition and mental health, along with critical care treatments such as plasmapheresis and hemodiafiltration.